Article
Acute Response of Peripheral Blood Cell to Autologous Hematopoietic Stem Cell Transplantation in Type 1 Diabetic Patient
22 Feb 2012
Abstract excerpt
OBJECTIVE: Autologous nonmyeloablative hematopoietic stem cell transplantation (AHST) was the first therapeutic approach that can improve β cell function in type 1 diabetic (T1D) patients. This study was designed to investigate the potential mechanisms involved. DESIGN AND METHODS: We applied AHST to nine T1D patients diagnosed within six months and analyzed the acute responses in peripheral blood for lymphocyte...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
